Table 1.

Factors to consider about common implementation tools

FACTORS TO CONSIDERIMPLEMENTATION TOOLS
PRINTED EDUCATIONAL MATERIAL*DECISION AIDS
Target audiences (Who is using the tool?)
  • Patients

  • Patients and clinicians

  • Patients, clinicians, and caregivers

  • Patients

  • Patients and clinicians

  • Patients, clinicians, and caregivers

Format (How is information presented?)
  • Infographic (eg, 1000-person diagram)

  • Frequently asked questions

  • Peer-reviewed publication of a clinical practice guideline

  • Infographic (eg, 1000-person diagram)

  • Algorithms

  • Decision trees

Content (What information is presented?)
  • Health outcomes of clinical interventions

  • Benefits and harms

  • Clinical risk scores

  • Best practices for the topic

  • Guideline recommendations

  • Decision under consideration is explicitly stated

  • Information on test or intervention

  • Benefits and harms

  • Prompt to consider values and preferences

  • Clinical risk scores

Passive dissemination (Examples of 1-way distribution of information to patients or physicians; no dialogue)
  • Review articles such as the following: CTFPHC. Recommendations on screening for developmental delay. CMAJ 2016;188(8):579–87.

  • Read the CTFPHC 1000-person handout that was distributed at a conference (eg, the Prostate Cancer—1000-Person Tool in Figure 1)4

  • Hospital distributes decision tree on surgical options to newly diagnosed patients with prostate cancer

Active implementation (Examples of 2-way exchange of information between patients and physicians; active dialogue)
  • Discuss the printed CTFPHC 1000-person handout with a patient as part of a discussion on screening (eg, Figure 1)4

  • Review a CTFPHC infographic with a patient as part of a screening decision discussion (eg, Figure 1)4

  • CTFPHC—Canadian Task Force on Preventive Health Care.

  • * Printed educational materials can also be delivered through videos, online applications, etc.

  • A diagram that shows a picture of 1000 individuals and the outcomes of screening for a condition for each person individually.